Actively Recruiting
Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations
Led by Ton-Bridge Medical Tech. Co., Ltd · Updated on 2024-09-19
170
Participants Needed
14
Research Sites
118 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to verify the efficacy and safety of the Liquid Embolic System (Tonbridge Medical Tech. Co., Ltd. (Suzhou)) for the treatment of cerebrovascular malformations.
CONDITIONS
Official Title
Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 80 years, any gender
- Suitable for endovascular treatment of cerebrovascular malformations
- Able to understand the study purpose, comply with the protocol, and provide signed informed consent
You will not qualify if you...
- Intracranial hemorrhage within 1 month before treatment
- Need for other treatments (surgery, radiosurgery, other embolic materials) in the embolization area during treatment
- Presence of other cerebrovascular malformations like cavernous vascular malformation
- Severe narrowing or blockage of brain arteries requiring surgery
- Brain tumors needing surgical treatment
- Modified Rankin Scale score of 3 or higher
- Severe heart, lung, liver, or kidney failure or other serious illnesses
- Known bleeding problems or coagulation disorders (INR >1.5)
- Known allergy to DMSO or contrast media or contraindication to anticoagulant therapy
- Pregnant, breastfeeding, or planning pregnancy during the study
- Participation in other drug or device clinical trials at consent
- Other conditions deemed unsuitable by investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 14 locations
1
Nanfang Hospital Southern Medical University
Guangzhou, Guangdong, China
Not Yet Recruiting
2
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China
Not Yet Recruiting
3
Henan Provincial People's Hospital
Zhengzhou, Henan, China
Not Yet Recruiting
4
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Active, Not Recruiting
5
General Hospital of Eastern Theater Command
Nanjing, Jiangsu, China
Not Yet Recruiting
6
The First Hospital of Jilin University
Changchun, Jilin, China
Not Yet Recruiting
7
General Hospital of Northern Theater Command
Shenyang, Liaoning, China
Not Yet Recruiting
8
Qilu Hospital of Shandong University
Jinan, Shandong, China
Not Yet Recruiting
9
Xuanwu hospital Capital Medical University
Beijing, China
Actively Recruiting
10
Sichuan Academy of Medical Sciences Sichuan Provincial People's Hospital
Chengdu, China
Actively Recruiting
11
Guangdong Provincial People's Hospital
Guangzhou, China
Not Yet Recruiting
12
Anhui Provincial Hospital
Hefei, China
Not Yet Recruiting
13
Jining No.1 People's Hospital
Jining, China
Not Yet Recruiting
14
Tongji Hospital Tongji Medical College of HUST
Wuhan, China
Not Yet Recruiting
Research Team
J
Jing Pan
CONTACT
J
Jin Zheng
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here